Abstract:Hypertension (HTN) can lead to heart and kidney damage. The gut microbiota has been linked to HTN, although it is difficult to estimate its significance due to the variety of other features known to influence HTN. In the present study, we used germ-free (GF) and colonized (COL) littermate mice to quantify the impact of microbial colonization on organ damage in HTN. Four-week-old male GF C57BL/6J littermates were randomized to remain GF or receive microbial colonization. HTN was induced by subcutaneous infusion with angiotensin (Ang) II (1.44 mg/kg/d) and 1% NaCl in the drinking water; sham-treated mice served as control. Renal damage was exacerbated in GF mice, whereas cardiac damage was more comparable between COL and GF, suggesting that the kidney is more sensitive to microbial influence. Multivariate analysis revealed a larger effect of HTN in GF mice. Serum metabolomics demonstrated that the colonization status influences circulating metabolites relevant to HTN. Importantly, GF mice were deficient in anti-inflammatory fecal short-chain fatty acids (SCFA). Flow cytometry showed that the microbiome has an impact on the induction of anti-hypertensive myeloid-derived suppressor cells and pro-inflammatory Th17 cells in HTN. In vitro inducibility of Th17 cells was significantly higher for cells isolated from GF than conventionally raised mice. Microbial colonization status of mice had potent effects on their phenotypic response to a hypertensive stimulus, and the kidney is a highly microbiota-susceptible target organ in HTN. The magnitude of the pathogenic response in GF mice underscores the role of the microbiome in mediating inflammation in HTN. To assess the potential of microbiota-targeted interventions to prevent organ damage in hypertension, an accurate quantification of microbial influence is necessary. We provide evidence that the development of hypertensive organ damage is dependent on colonization status and suggest that a healthy microbiota provides anti-hypertensive immune and metabolic signals to the host. In the absence of normal symbiotic host-microbiome interactions, hypertensive damage to the kidney in particular is exacerbated. We suggest that hypertensive patients experiencing perturbations to the microbiota, which are common in CVD, may be at a greater risk for target-organ damage than those with a healthy microbiome.

Microbiota Introduced to Germ-Free Rats Restores Vascular Contractility and Blood Pressure

Abstract P149: Germ-free Rats Reveal An Obligatory Role Of Microbiota In Blood Pressure

The gut microbiome and hypertension

Abstract P112: Elevated Blood Pressure In Conventionalized Germ-free Rats Is Coupled With Upregulation Of Kynurenic Pathway Metabolites And Central Immune Responses

Critical Role of the Interaction Gut Microbiota – Sympathetic Nervous System in the Regulation of Blood Pressure

Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats

Fecal Microbiota Transplantation Regulates Blood Pressure by Altering Gut Microbiota Composition and Intestinal Mucosal Barrier Function in Spontaneously Hypertensive Rats

The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?

Microbiota and Metabolites as Factors Influencing Blood Pressure Regulation

Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage

Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications

Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages

Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first‐line antihypertensive drugs

Microbial influence on blood pressure: unraveling the complex relationship for health insights

Intestinal serotonergic vagal signaling as a mediator of microbiota-induced hypertension

Effects of fecal microbiota transfer on blood pressure in animal models: A systematic review and meta-analysis

Restructuring the Gut Microbiota by Intermittent Fasting Lowers Blood Pressure

Gut Microbiome over a Lifetime and the Association with Hypertension

Increased Abundance of Lactobacillales in the Colon of Beta-Adrenergic Receptor Knock Out Mouse Is Associated With Increased Gut Bacterial Production of Short Chain Fatty Acids and Reduced IL17 Expression in Circulating CD4+ Immune Cells

Gut microbiota dysbiosis contributes to the development of hypertension

Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review